Pilot study opens the door to a promising new therapeutic alternative for PTSD patients
PTSD, or post-traumatic stress disorder, doesn't discriminate. It affects about 15 million adults in the U.S. each year.
Stay updated with breaking news from Breakthrough Device Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PTSD, or post-traumatic stress disorder, doesn't discriminate. It affects about 15 million adults in the U.S. each year.
Boston, MA (PRWEB) February 22, 2022 -- DynamiCare Health Inc., a digital therapeutics and telehealth company dedicated to helping people overcome addiction,
Comaneci temporarily expands blood vessels-recognized as novel device for life-threatening disease Rapid Medical, a leading developer of advanced neurovascular devices, today announced FDA breakthrough
/PRNewswire/ -- Cardiosense, Inc., a Chicago-based digital health company building a physiological waveform AI platform to manage cardiac disease, announced...
/PRNewswire/ -- Pathogenomix Inc., a Next Generation Sequencing, pathogen diagnostic company, announced that the US Food and Drug Administration (FDA) has...